Dichotomous assessments of homologous recombination deficiency are insufficient predictive biomarkers for the PARP inhibitor treatment of ovarian cancer
Clinical and Translational Medicine · 2026-11 · 16 (11)
DOI: 10.1002/ctm2.70890 ↗Kurz gefasst
Leserbrief in der Zeitschrift Clinical and Translational Medicine, online erschienen am 01.11.2026. Verfasst von Jesenia M Perez und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Minnesota School of Medicine, Minneapolis, Minnesota, USA. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Medicine, University of Minnesota School of Medicine, Minneapolis, Minnesota, USA.
- Department of Obstetrics, Gynecology and Women's Health, University of Minnesota School of Medicine, Minneapolis, Minnesota, USA.
- Department of Laboratory Medicine and Pathology, University of Minnesota School of Medicine, Minneapolis, Minnesota, USA.
ORCID-Profile: Justin Hwang, Stefani N Thomas
Förderung
- NCI NIH HHS
Zitieren
APA
Perez, J. M., Hwang, J., Erickson, B. K., & Thomas, S. N. (2026). Dichotomous assessments of homologous recombination deficiency are insufficient predictive biomarkers for the PARP inhibitor treatment of ovarian cancer. Clinical and Translational Medicine, 16(11). https://doi.org/10.1002/ctm2.70890
Vancouver
Perez JM, Hwang J, Erickson BK, Thomas SN. Dichotomous assessments of homologous recombination deficiency are insufficient predictive biomarkers for the PARP inhibitor treatment of ovarian cancer. Clinical and Translational Medicine. 2026;16(11). doi:10.1002/ctm2.70890
BibTeX
@article{Perez2026,
author = {Perez, Jesenia M and Hwang, Justin and Erickson, Britt K and Thomas, Stefani N},
title = {Dichotomous assessments of homologous recombination deficiency are insufficient predictive biomarkers for the PARP inhibitor treatment of ovarian cancer},
journal = {Clinical and Translational Medicine},
year = {2026},
volume = {16},
number = {11},
doi = {10.1002/ctm2.70890}
}
EUVIMED